Angahin Matin

Title: Innovations of Angahin Matin in Cancer Research

Introduction

Angahin Matin is a notable inventor based in Houston, Texas, recognized for his contributions to cancer research. He has developed innovative methods aimed at suppressing neu-mediated tumors, which have significant implications for cancer treatment.

Latest Patents

Matin holds a patent titled "Methods for the suppression of neu mediated tumors by adenoviral E1A." This patent discloses methods and compositions for suppressing the expression of the neu oncogene, as well as its associated tumorigenesis and metastasis. The invention involves the introduction of adenovirus early 1A gene (E1A gene) products into affected cells, which serve to reduce the expression of the neu oncogene. The results indicate a reduction in cell growth and oncogenic potential, suggesting that these methods may be employed as treatment modalities for neu-mediated cancers, including those of the female genital tract and breast.

Career Highlights

Angahin Matin is affiliated with the University of Texas System, where he continues to advance his research in oncology. His work has garnered attention for its potential to transform cancer treatment strategies.

Collaborations

Matin collaborates with esteemed colleagues, including Yujiao Joe Zhang and Mien-Chie Hung, who contribute to the research and development of innovative cancer therapies.

Conclusion

Angahin Matin's work exemplifies the intersection of innovation and medical research, particularly in the fight against cancer. His patented methods offer promising avenues for future treatments, highlighting the importance of continued research in this critical field.